Research and News Involving:
University of Michigan
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Virtual Pitch Event on June 11 Features 5 Clinical Repurposing Projects April 21, 2020...
Adult, Children's Hospital of Philadelphia, Clinical Trials, Dr. Fleischman, Dr. Park, Dr. Phillips, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare Disease, Stanford University, University of California Davis, University of California Irvine, University of Michigan
Press Release: University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial in Myeloproliferative Neoplasms Receives Funding to...
Adult, Brigham Young University, Clinical Trials, Dr. Ghosh, Dr. Ito, Dr. Ohanian, Dr. Romancik, Dr. Watt, Drug, Emory University, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center, University of Michigan, University of Pittsburgh
Press Release: Five clinical trials impacting blood cancers approved for funding Five clinical trials impacting blood cancers approved for funding Cures Within Reach partnered with Goldman Philanthropic Partnerships, Leukemia Research Foundation and individual donors...
Adult, Current Research, Dr. Ghosh, Drug, Oncology, Rare Disease, University of Michigan
Reducing CAR T-cell therapy complications in relapsed lymphoma patients by adding natalizumab Principal Investigator: Dr. Monalisa Ghosh Disease: Relapsed Lymphoma Research Description: Chimeric antigen receptor (CAR) T-cell therapy offers new hope through...
Adult, CureAccelerator Live!, Dr. Phillips, Drug, Minority/Underrepresented, Oncology, Rare Disease, University of Michigan
Improving Patient Response in Mantle Cell Lymphoma with Venetoclax Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is diagnosed mostly in older...
Adult, Current Research, Dr. Zacks, Drug, Ophthalmic, Rare Disease, University of Michigan
Testing a Generic Malarial Drug in a Rare Ophthalmic Condition, Retinitis Pigmentosa Principal Investigator: Dr. David Zacks Disease: Retinitis Pigmentosa Research Description: Certain mutations are a common cause of retinitis pigmentosa (RP), a rare ophthalmic...
Adult, Completed Research, CureAccelerator Live!, Dr. Swiecicki, Drug, Longest Day of Golf, Oncology, Rare Disease, University of Michigan
Repurposing Old Drugs as New Therapies for Metastatic Thyroid Cancer Principal Investigator: Dr. Paul Swiecicki Disease: Thyroid Cancer Research Description: Thyroid cancer is the sixteenth most common malignancy in the world. Although most patients are cured with a...
Adult, Dr. Pettit, Drug, Oncology, Rare Disease, University of Michigan
Using a Skin Cancer Drug to Improve Current Treatment in a Rare Blood Cancer, Myelofibrosis Principal Investigator: Dr. Kristen Pettit Disease: Myelofibrosis Research Description: Myelofibrosis (MF) is a rare, aggressive bone marrow cancer causing excessive scar...
